Member Contact: Mark Diamond
Position: CEO & Managing Director
Industry: Biotech & Pharmaceuticals
"Antisense Therapeutics' strategy is:
• to create antisense drugs for diseases where there are large and/or poorly met markets, in collaboration with Antisense Therapeutics’ technology and research partners
• to out-source preclinical and clinical testing of the candidate drugs to expert contractors
• to commercialise the drugs that are shown to be successful in pre-clincal and/or clinical testing by entering into licensingdeals or other partnerships with major pharmaceutical companies."